Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CADL | Candel Therapeutics, Inc. | Chief Financial Officer | $182K | Nov 28, 2023 | ||
ACER | Acer Therapeutics Inc. | Director | Mar 14, 2023 | |||
TCRX | TScan Therapeutics, Inc. | Chief Financial Officer | Feb 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|